TrialAntimicrobial agents and chemotherapy2019

Intravenous Immunoglobulin Administration Significantly Increases BKPyV Genotype-Specific Neutralizing Antibody Titers in Kidney Transplant Recipients.

Aurélie Velay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.